#Pembrolizumab

Sandip Patel MD

PatelOncology

KEYNOTE-158 study out in Lancet Oncology, Pembrolizumab for TMB>10- most data time date we have seen since FDA approval, key aspects include tumor types studiedhttps://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30445-9/fu

Lorand Kis

kis_lorand

Spindle cell tumor in the dermis. Any thoughts on what it could be? #pathology #IHCpath #dermpath 1. Thanks everyone for engaging!!! Differential diagnosis includes and is not limited to:Benign lesions/tumors-

Shrey Srivastava

BlogShrey

#DDDD #4Dpharma's MRx051 trial found "relative increases in cytotoxic cells, CD8+ T cells and other immune subsets associated with anti-tumour activity". A very good start to the long road to

Pashtoon Kasi MD, MS

pashtoonkasi

Another agnostic approval.#Pembrolizumab #TMBTMB cutoff >=Though I’m overall very supportive of agnostic approvals overall, not sure if TMB is the same across tissue types. @US_FDA #OncoAlert #PrecisionMedicine https://seekingalpha.com

Amit Kulkarni

AmitKulkarniMD

#FDA recently approved #pembrolizumab- a tissue agnostic indication in metastatic tumors with high #TMB (>10 mut/MB) using Foundation One Dx companion diagnostic test. I want to share a tweetorial on

Sarah Blagden

sarah_blagden

Some of our cancer patients have been refused COVID vaccines. I thought I'd summarise guidance (taken from UK chemotherapy Board, Thames Valley Haematology and PHE guidelines) that applies to Oxford

Vivek Subbiah, MD

VivekSubbiah

By popular demand The Top 10 clinical publications in Oncology in 2020 (In no particular order). Some important papers bundled + Additional 5 more papers representing major advances in the

Matt Henkel

mph_turf79

I am speechless about the events of this past week. From the lows of needing to start hospice due to my rapidly growing #Gbm #cancer ,to getting a call from

WarrenPuffett

warrenpuffettt

$LOAC Thread: My new swing that I will be holding through January. This is my favorite non EV SPAC for many reasons A little background: $LOAC is merging with @4dpharmaplc

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.